Status:
RECRUITING
Risk of Nerve Damage After Administration of Local Anesthesia
Lead Sponsor:
Cleveland Dental Institute
Conditions:
Inferior Alveolar Nerve Injuries
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Tria...
Eligibility Criteria
Inclusion
- Patients with age between 18-55 years old
- Patients need IANB
- healthy patient
Exclusion
- medical conditions
- allergies
- medications
- pregnancy and breastfeeding
- inability to provide informed consent
- specific dental or medical history.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06564987
Start Date
January 1 2024
End Date
March 31 2025
Last Update
August 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Dental Institute
Akron, Ohio, United States, 44703
2
Cleveland Dental Institute
Ashtabula, Ohio, United States, 44004